Skip to main content
. 2023 Jan 23;7:e2200436. doi: 10.1200/PO.22.00436

TABLE 3.

Larotrectinib Versus SoC: Overall Survival From Time of Metastatic/Locally Advanced Diagnosis Index Date

graphic file with name po-7-e2200436-g004.jpg